We recently published a list of 10 Stocks With At Least $30 Million In Insider Sales Recently. In this article, we are going ...

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

With a market cap of $50.5 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global healthcare solutions ...

Key Indicators: Cencora's Financial Health Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong ...

Shares of Cencora Inc. COR slid 2.56% to $254.00 Wednesday, on what proved to be an all-around mixed trading session for the ...

Equities research analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for Cencora in a note ...

It has been about a month since the last earnings report for Cencora (COR ... year over year. The company recorded an adjusted operating income of $949.3 million, up 7.2% year over year.

Mizuho started coverage on shares of Cencora in a research note on Wednesday, December 4th. They set an “outperform” rating and a $280.00 target price for the company. Robert W. Baird boosted ...

The latest sale of Cencora common stock will give Deerfield-based Walgreens proceeds of about $265 million, the company said in a statement, and it will take in another $50 million in a share ...